Equal reimbursement parity for anticancer regimens regardless of delivery method including, but not limited to oral and intravenous drugs, injections, surgery, radiation, transplantation, etc.
The Patients Equal Access Coalition (PEAC) is a patient focused coalition of organizations representing patients, health care professionals, care centers, and industry collaboratively joined together to ensure that cancer patients have equality of access (and equality of insurance coverage) to all approved anticancer regimens including, but not limited to oral and intravenous drugs, injections, surgery, radiation, transplantation, etc. PEAC believes that every cancer patient should have access to the anticancer regimens recommended by their physicians and should not suffer from cost discrimination based on the type of therapy provided or the mechanism of delivery.
Due to an outdated insurance benefit design, cancer patients across the country are not able to afford their oral anticancer medications. Please take a moment to hear from the patients themselves, and learn about what we are doing to find a solution.
TThe Patients Equal Access Coalition Applauds a New Bill to Improve Access to Oral Anticancer Drugs
Washington, DC, March 9, 2017—Today the Patients Equal Access Coalition (PEAC) commends Congressmen Leonard Lance (R-NJ-7th District) and Brian Higgins (D-NY-26th District) on the introduction of the Cancer Drug Parity Act of 2017, H.R. 1409. This bill is a critical step toward improving access to anticancer treatments by requiring insurance companies to cover patient-administered and physician-administered anticancer drugs at the same cost to patients.